Merck & Co., Inc. (MRK)
NYSE: MRK · Real-Time Price · USD
89.50
+1.82 (2.08%)
At close: Feb 21, 2025, 4:00 PM
89.34
-0.16 (-0.18%)
After-hours: Feb 21, 2025, 7:53 PM EST
Merck & Co. Revenue
In the year 2024, Merck & Co. had annual revenue of $64.17B with 6.74% growth. Merck & Co. had revenue of $15.62B in the quarter ending December 31, 2024, with 6.79% growth.
Revenue (ttm)
$64.17B
Revenue Growth
+6.74%
P/S Ratio
3.54
Revenue / Employee
$891,222
Employees
72,000
Market Cap
226.40B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 64.17B | 4.05B | 6.74% |
| Dec 31, 2023 | 60.12B | 832.00M | 1.40% |
| Dec 31, 2022 | 59.28B | 10.58B | 21.72% |
| Dec 31, 2021 | 48.70B | 7.19B | 17.31% |
| Dec 31, 2020 | 41.52B | 2.40B | 6.13% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 400.28B |
| Johnson & Johnson | 88.82B |
| AbbVie | 56.33B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.88B |
| Abbott Laboratories | 41.95B |
MRK News
- 1 day ago - Securities Fraud Investigation Into Merck & Co (MRK) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm - Business Wire
- 1 day ago - I'm Buying Discounted Dividend Icons Up To 6% Yield - Seeking Alpha
- 1 day ago - Merck & Co (MRK) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation - Business Wire
- 2 days ago - Securities Fraud Investigation Into Merck & Co (MRK) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - Business Wire
- 2 days ago - 10 Ideal 'Safer' January Dividend Buys, Out Of 40 Choices From Readers - Seeking Alpha
- 2 days ago - SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co. - GlobeNewsWire
- 3 days ago - Exclusive: Merck vaccine case linked to HHS Secretary Kennedy delayed, company says - Reuters
- 3 days ago - WELIREG® (belzutifan) Receives First European Commission Approval for Two Indications - Business Wire